Live from Psychedelic Science - Part I Research

The first episode of our three part series, Live from Psychedelic Science, focuses on research.  We interview five leaders in the field whose work runs the gamut from generating novel molecules to patient care.  We kick off the episode with back to back chemist entrepreneurs who work at the cutting edge of psychedelic drug development.  From there we hear from the psychedelics program manager at one of the world’s largest medical research institutions.  Next, we get an international perspective by engaging with Brazil’s leading clinical researcher of ayahuasca, pure DMT, and ketamine.  We close out the episode with an experienced integrative medicine doctor and patient advocate.  

Interviewers

Nigam B. Arora, PhD

Neil Ritter, PhD

Interviewees

Andrew Bartynski, PhD - VP of Operations at Alexander Shulgin Research Institute (2:58)

Jackie von Salm, PhD - Co-founder and CSO at Psilera (14:31)

Lauriane Sibileau, MSc - Program Manager at Center for Neuroscience of Psychedelics at Mass General Hospital  (25:13)

Nicole Galvão-Coelho, PhD - Professor of Physiology & Behavior at Federal University of Rio Grande do Norte and Adjunct Professor at Western Sydney University (34:51)

Harry McIlroy, MD - Integrative Medicine Doctor at BioReset Medical and Chair of the Board of Directors at Chacruna Institute (52:58)

Credits:

Cover art by Julia Boot. Podcast audio engineering by Joe Leonardo. Intro music by Buddha by Kontekst. Transition music by K. LOUK. Outro music by Bensounds.